By raising ₹500-600 crore, this firm aims to strengthen its market position and adapt to evolving global trends.

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

Previously, searches for “SafeCard consumer reports” and “SafeCard Reviews” are increasing widely in the market. Also, there are several questions for this card like as safety advice, how it functions ...

MALVERN, Pa., Jan. 31, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical ...

Nasdaq president Nelson Griggs discusses the decline of companies going public and when the incentive for initial public offerings will return.

Oil company Natural Resources and medical-device maker Beta Bionics shrug off a down market to gain in their trading debuts.

Apollo offers its first tokenized fund to widen its appeal to a broader range of investors. Private Credit and Tokenization ...